Yi Ban

2.2k total citations · 1 hit paper
22 papers, 1.3k citations indexed

About

Yi Ban is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yi Ban has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Immunology. Recurrent topics in Yi Ban's work include Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Cells and Metastasis (4 papers). Yi Ban is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Cells and Metastasis (4 papers). Yi Ban collaborates with scholars based in United States, China and Japan. Yi Ban's co-authors include Yi Lisa Lyu, Leroy F. Liu, Chao‐Po Lin, Anna M. Azarova, Yuan‐Chin Tsai, John E. Kerrigan, Xiaojing Ma, Dingcheng Gao, Vivek Mittal and Sharrell B. Lee and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Immunology.

In The Last Decade

Yi Ban

22 papers receiving 1.3k citations

Hit Papers

Copper depletion modulates mitochondrial oxidative phosph... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Ban United States 14 567 556 341 215 181 22 1.3k
Tejaswitha Jairaj Naik United States 6 561 1.0× 416 0.7× 546 1.6× 240 1.1× 174 1.0× 6 1.4k
Rosaria Cammarota Italy 7 285 0.5× 339 0.6× 427 1.3× 93 0.4× 113 0.6× 8 969
Mariarosaria Conte Italy 22 1.1k 1.9× 287 0.5× 127 0.4× 84 0.4× 141 0.8× 50 1.6k
Xinyong Cai China 14 423 0.7× 153 0.3× 403 1.2× 76 0.4× 132 0.7× 35 960
Shibu Thomas United States 21 634 1.1× 412 0.7× 105 0.3× 110 0.5× 521 2.9× 71 1.5k
Steven Sugarman United States 14 453 0.8× 544 1.0× 123 0.4× 113 0.5× 83 0.5× 20 1.2k
Lang Hong China 14 378 0.7× 164 0.3× 450 1.3× 54 0.3× 102 0.6× 35 939
M. Lakshmi Kuppusamy United States 24 546 1.0× 201 0.4× 105 0.3× 79 0.4× 96 0.5× 39 1.4k
Gregory J. Aune United States 14 768 1.4× 470 0.8× 351 1.0× 32 0.1× 172 1.0× 24 1.4k
Wilhelmina Duivenvoorden Canada 20 431 0.8× 374 0.7× 80 0.2× 71 0.3× 401 2.2× 49 1.2k

Countries citing papers authored by Yi Ban

Since Specialization
Citations

This map shows the geographic impact of Yi Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ban more than expected).

Fields of papers citing papers by Yi Ban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ban. The network helps show where Yi Ban may publish in the future.

Co-authorship network of co-authors of Yi Ban

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Ban. A scholar is included among the top collaborators of Yi Ban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Ban. Yi Ban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Markowitz, Geoffrey J., Yi Ban, Enrique Podaza, et al.. (2024). Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy. Nature Immunology. 25(10). 1884–1899. 18 indexed citations
4.
Markowitz, Geoffrey J., Yi Ban, Michael J. Crowley, et al.. (2022). 965 Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway to generate TCF1+ progenitor CD8 T cells to improve efficacy of PD-1 checkpoint blockade. Regular and Young Investigator Award Abstracts. A1006–A1007. 1 indexed citations
5.
Ban, Yi, Geoffrey J. Markowitz, Yue Zou, et al.. (2021). Radiation-activated secretory proteins of Scgb1a1+ club cells increase the efficacy of immune checkpoint blockade in lung cancer. Nature Cancer. 2(9). 919–931. 32 indexed citations
6.
Ramchandani, Divya, Mirela Berisa, Zhuoning Li, et al.. (2021). Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis. Nature Communications. 12(1). 7311–7311. 204 indexed citations breakdown →
7.
Zhan, Wenhu, Pradeep K. Singh, Yi Ban, et al.. (2020). Structure–Activity Relationships of Noncovalent Immunoproteasome β5i-Selective Dipeptides. Journal of Medicinal Chemistry. 63(21). 13103–13123. 11 indexed citations
9.
Markowitz, Geoffrey J., Lauren S. Havel, Michael J. Crowley, et al.. (2018). Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival. JCI Insight. 3(13). 48 indexed citations
10.
Gao, Dingcheng, Vivek Mittal, Yi Ban, et al.. (2018). Metastatic tumor cells – genotypes and phenotypes. Frontiers in Biology. 13(4). 277–286. 16 indexed citations
11.
Ban, Yi, Junhua Mai, Xin Li, et al.. (2017). Targeting Autocrine CCL5–CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity. Cancer Research. 77(11). 2857–2868. 122 indexed citations
12.
Ma, Xiaojing, et al.. (2017). Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residues. Carbohydrate Research. 443-444. 73–77. 10 indexed citations
13.
Zheng, Hua, Yi Ban, Fang Wei, & Xiaojing Ma. (2016). Regulation of Interleukin-12 Production in Antigen-Presenting Cells. Advances in experimental medicine and biology. 941. 117–138. 46 indexed citations
14.
Ban, Yi, et al.. (2013). Activation of a Novel Ubiquitin-Independent Proteasome Pathway when RNA Polymerase II Encounters a Protein Roadblock. Molecular and Cellular Biology. 33(20). 4008–4016. 22 indexed citations
15.
Lin, Chao‐Po, Yi Ban, Yi Lisa Lyu, & Leroy F. Liu. (2009). Proteasome-dependent Processing of Topoisomerase I-DNA Adducts into DNA Double Strand Breaks at Arrested Replication Forks. Journal of Biological Chemistry. 284(41). 28084–28092. 62 indexed citations
16.
Lin, Chao‐Po, Yi Ban, Yi Lisa Lyu, Shyamal D. Desai, & Leroy F. Liu. (2008). A Ubiquitin-Proteasome Pathway for the Repair of Topoisomerase I-DNA Covalent Complexes. Journal of Biological Chemistry. 283(30). 21074–21083. 95 indexed citations
17.
Lyu, Yi Lisa, John E. Kerrigan, Chao‐Po Lin, et al.. (2007). Topoisomerase IIβ–Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane. Cancer Research. 67(18). 8839–8846. 475 indexed citations
18.
Xiao, Jun‐Hua, et al.. (2007). Effect of 2,3,5,4′-tetrahydroxystilbene-2-O-beta-d-glucoside on lipoprotein oxidation and proliferation of coronary arterial smooth cells. Journal of Asian Natural Products Research. 9(8). 689–697. 47 indexed citations
19.
Taniyama, Matsuo, et al.. (2001). Association of the mitochondrial DNA 5178A/C polymorphism with maternal inheritance and onset of type 2 diabetes in Japanese patients. Experimental and Clinical Endocrinology & Diabetes. 109(7). 361–364. 43 indexed citations
20.
Jinno, Kiyokatsu & Yi Ban. (1990). Computer-assisted prediction of small peptide sequencing in reversed-phase liquid chromatography. Chromatographia. 30(1-2). 51–56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026